Overview

Comparison of Anti-Xa Activity of ENOXA ® Versus LOVENOX ® in Acute Coronary Syndrome

Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
This study is a clinical trial monocentric, open, randomized ENOXA ® versus LOVENOX ®, conducted on two parallel groups of patients admitted in emergency for acute coronary syndrome.
Phase:
Phase 4
Details
Lead Sponsor:
Les Laboratoires des Médicaments Stériles
Collaborator:
University Hospital Fattouma Bourguiba
Treatments:
Dalteparin
Enoxaparin
Heparin, Low-Molecular-Weight